Low cholesterol levels are good markers for central hypothyroidism in case with dialysis using roxadustat-Reference-Cited by-同舟云学术

Low cholesterol levels are good markers for central hypothyroidism in case with dialysis using roxadustat

Published:2024-09 Issue:9 Volume:12 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Kita Serina¹^ORCID,Okuyama Hiroshi²,Kondo Takaya¹,Hayashi Mizuki¹,Nakao Shinichiro¹,Sawamura Toshitaka²,Fujimoto Keiji¹,Nakagawa Atsushi³,Yokoyama Hitoshi¹,Furuichi Kengo¹

Affiliation:

1. Department of Nephrology Kanazawa Medical University Kahoku‐gun Japan

2. Asanogawa General Hospital Kanazawa Japan

3. Department of Diabetology and endocrinology Kanazawa Medical University Kahoku‐gun Japan

Abstract

Key Clinical MessageRecently, hypoxia‐inducible factor prolyl hydroxylase (HIF‐PH) inhibitors have been used for renal anemia, but side effects have also been reported. We report on the association of central hypothyroidism and cholesterol with roxadustat. Based on this case and previous reports, we believe that patients receiving roxadustat should have their thyroid function and cholesterol levels checked regularly.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.9400

Reference14 articles.

1. Prevalence of anemia in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB)

2. Hypoxia-inducible factor prolyl hydroxylase inhibitors: a paradigm shift for treatment of anemia in chronic kidney disease?

3. Effect of Roxadustat on Thyroid Function in Patients With Renal Anemia

4. HIF‐alpha prolyl hydroxylase inhibitors and their implications for biomedicine: a comprehensive review;Hirota K;Biomedicine,2021

5. Suppression of thyrotropin secretion during roxadustat treatment for renal anemia in a patient undergoing hemodialysis